IRIS PubliCatt

Giampietro, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.367
NA - Nord America 2.248
AS - Asia 719
AF - Africa 15
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.235
DE - Germania 986
SE - Svezia 393
CN - Cina 298
IT - Italia 297
SG - Singapore 235
UA - Ucraina 176
IE - Irlanda 116
FR - Francia 101
ID - Indonesia 81
GB - Regno Unito 67
RU - Federazione Russa 60
PL - Polonia 58
FI - Finlandia 47
IN - India 42
BE - Belgio 24
NL - Olanda 15
IR - Iran 14
JP - Giappone 13
CA - Canada 12
TR - Turchia 12
CI - Costa d'Avorio 9
HK - Hong Kong 9
VN - Vietnam 6
CO - Colombia 4
CZ - Repubblica Ceca 4
KR - Corea 4
BG - Bulgaria 3
ES - Italia 3
EU - Europa 3
MD - Moldavia 3
PT - Portogallo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BR - Brasile 2
GH - Ghana 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
NG - Nigeria 1
RS - Serbia 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 5.363
Salva come PNG Salva come JPEG
Città #
Chandler 582
Singapore 183
Ashburn 131
Dublin 108
San Mateo 108
New York 105
Ann Arbor 82
Jakarta 81
Jacksonville 72
Fairfield 68
Wilmington 68
Rome 65
Marseille 61
Nürnberg 55
Boston 53
Warsaw 53
Milan 48
Nanjing 47
Bremen 44
Cattolica 40
Moscow 40
Princeton 40
Seattle 36
Dearborn 34
Los Angeles 32
Houston 31
Redwood City 31
Woodbridge 29
Munich 26
Nanchang 24
Brussels 23
Cambridge 23
Beijing 21
Hangzhou 21
Lawrence 21
Shanghai 21
Boardman 20
Mountain View 20
Zhengzhou 19
Helsinki 17
University Park 17
Chicago 16
Shenyang 15
Fremont 14
Guangzhou 12
Norwalk 12
Augusta 11
Leawood 11
Hebei 10
Izmir 10
Kunming 10
Abidjan 9
Hong Kong 9
Kish 9
Redmond 9
Changsha 8
Lancaster 8
Brescia 7
Mumbai 7
Piacenza 7
Pune 7
Washington 7
Andover 6
Canterbury 6
Jiaxing 6
London 6
Paris 6
Tianjin 6
Toronto 6
West Jordan 6
Hanoi 5
Menlo Park 5
Renton 5
Santa Clara 5
Amsterdam 4
Campobasso 4
Cornaredo 4
Monmouth Junction 4
Sakaemachi 4
Utrecht 4
Ardabil 3
Bari 3
Brno 3
Chisinau 3
Dalmine 3
Frankfurt am Main 3
Fuzhou 3
Gunzenhausen 3
Indiana 3
Jinan 3
Krasnodar 3
Mercato San Severino 3
Ningbo 3
Nuremberg 3
Petrozavodsk 3
Sacramento 3
Ypsilanti 3
Accra 2
Barbarano Vicentino 2
Bergamo 2
Totale 2.957
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 233
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 233
Double pituitary adenomas 191
Male fertility and reduction in semen parameters: A single tertiary-care center experience 152
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 149
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 141
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 140
Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF [Il ruolo di un approccio chirurgico mini-invasivo nella diagnosi e trattamento della sterilità tubo-peritoneale in alternativa alla FIVET] 138
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 133
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 130
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 127
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 122
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 119
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 106
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 105
Isolated growth hormone deficiency: clinical entity? 103
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 103
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 100
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 100
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 96
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 96
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 94
Fertility and hypopituitarism 93
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 93
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 91
The Changing Clinical Spectrum of Hypophysitis 91
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 86
GH receptor isoforms and skeletal fragility in acromegaly 84
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 80
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 77
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 67
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 67
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 67
Vertebral fractures in patients with acromegaly: a 3-year prospective study 63
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 62
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism 61
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 60
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 60
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 59
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 58
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 56
Empty sella syndrome: Multiple endocrine disorders. 54
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 54
Solitary Metastatic Melanoma of the Pituitary Gland: Report of Two Cases and Literature Review 53
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 52
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 52
Understanding the effect of acromegaly on the human skeleton. 51
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 50
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 49
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 48
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 48
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 48
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 46
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 45
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 45
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 43
Acromegaly can be cured by first-line pasireotide treatment? 42
Hypothalamitis and pituitary atrophy 42
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 36
Acromegaly in the elderly patients 36
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 34
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 33
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 23
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 21
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 19
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 16
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 12
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 11
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 10
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 10
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 10
De-escalation treatment with pasireotide for acromegaly: a long-term experience 9
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 9
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 8
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 8
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 7
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 7
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 7
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 6
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 5
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 5
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 4
Totale 5.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 43 53 108 35 35 46 67 32
2020/2021419 20 42 11 42 50 27 47 9 43 55 68 5
2021/2022617 30 33 7 47 74 27 10 112 28 26 85 138
2022/20231.516 173 207 123 252 80 211 89 127 157 13 53 31
2023/2024717 32 160 17 32 31 142 35 8 28 34 93 105
2024/2025361 30 40 124 75 92 0 0 0 0 0 0 0
Totale 5.454